Clinical Trials Logo

Clinical Trial Summary

The objective of the study is to clinically assess the safety and effectiveness of LIQOSEAL® as a means of reducing intra- as well as post-operative CSF leakage in patients undergoing elective cranial intradural surgery with a dural closure procedure to show noninferiority compared to a control group.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04086550
Study type Interventional
Source Polyganics BV
Contact Andrew Carlson
Phone # 505 272 6094
Email AndrewCarlson@salud.unm.edu
Status Recruiting
Phase N/A
Start date May 20, 2021
Completion date January 2024

See also
  Status Clinical Trial Phase
Completed NCT04057157 - Post-market Assessment of Biodesign Dural Repair Grafts
Withdrawn NCT02902133 - Acetazolamide to Prevent Post Operative CSF Leak Phase 2
Recruiting NCT02927782 - Mobilisation Algorithm After Incidental Durotomy N/A
Completed NCT03566602 - Evaluate the Safety and Performance of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery N/A
Completed NCT02891070 - Efficacy and Safety of FS VH S/D 500 S-apr (Tisseel) as an Adjunct to Sutured Dural Repair in Cranial Surgery Phase 3
Recruiting NCT04490629 - The Efficacy and Safety of a Latest Dural Substitute N/A
Withdrawn NCT04351061 - Acetazolamide for the Prevention of Post Operative CSF Leak Phase 2
Completed NCT02457546 - The EVICEL® Neurosurgery Phase III Study Phase 3
Completed NCT04145544 - A Prospective, Randomized, Controlled Multi-center Study of ArtiFascia® Dural Repair Patch Compared With Commercially Available Dural Substitutes. To Evaluate the Safety and Effectiveness of ArtiFascia® in Subjects Requiring Dural Repair. N/A
Completed NCT04124523 - Perioperative CSF Leak Management - an Opinion Study
Active, not recruiting NCT04923867 - Suturable DuraGen™ PMCF Study
Withdrawn NCT03181464 - Sphenopalatine Ganglion Nerve Block for Postdural Puncture Headache in Obstetrics Phase 4